Newsletter | December 17, 2024

12.17.24 -- AstraZeneca's Digitally Connected Strategy For API Manufacturing

SPONSOR

Challenging the Norm: Smaller Partners, Bigger Impact

In our outsourcing industry, it is never an easy decision to select a partner when trying to run complex sequential trials. The need to gain regulatory approval for the treatments you have dedicated yourself to providing, coupled with the need to find a capable, reliable, and fair Contract Research Organization is quite daunting. Discover how a smaller full-service partner may be better suited to see your study through.

FEATURED EDITORIAL

AstraZeneca's Digitally Connected Strategy For API Manufacturing

The company's packing in the latest technology at its APICOM facility in Dublin. A key feature is more effective and timely use of process data.

INDUSTRY INSIGHTS

Treating Deficiencies In Employee Training And Mentorship

Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.

The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics

By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

Integrating Early Development With Clinical Supply

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

SOLUTIONS

Perceptive eClinical